We have previously shown in a functional screening in GBM that several splicing regulators are among highly expressed RBPs affecting cancer phenotypes.61 Importantly, a growing number of specific splicing factor inhibitors are being identified, and their use in cancer therapy is gaining momentum.24 Here, SLU7 is linked to glioblastoma.